FULL PAPERS
CDCl3): d=À76.1 (s, 3F); IR (film): n=3456, 3402, 3132,
2844, 1582, 1508, 1443, 1330, 1267, 1242, 1165, 1092, 1051,
883, 834, 739, 723 cmÀ1; LR-MS (ESI): m/z=322.1, mass cal-
culated for [M+H]+ (C17H15F3NO2): 322.11; the enantiomer-
ic excess was determined by HPLC analysis using a Chiral-
pakꢂ IA column (hexane/i-PrOH: 83/13, flow rate
1.0 mLminÀ1, l=225 nm): ent-minor tr =7.1 min and ent-
major tr =10.6 min.
(S)-2,2,2-Trifluoro-1-(1H-indol-3-yl)-1-(naphthalen-2-yl)-
AHCTUNGTRENNUNG
(R)-2,2,2-Trifluoro-1-(1H-indol-3-yl)-1-(2-methoxyphen-
1
N
(400 MHz, CDCl3): d=8.20 (s, 1H, NH), 7.36–7.27 (m, 2H),
7.23–7.19 (m, 2H), 7.11 (ddd, J=8.2, 7.0, 1.1 Hz, 1H), 7.03
(dm, J=7.8, 1H), 7.02 (dd, J=8.3, 1.0 Hz, 1H), 6.94 (ddd,
J=8.0, 7.0, 1.0 Hz, 1H), 6.84–6.78 (m, 1H), 6.55 (s, 1H,
OH), 3.92 (s, 3H, CH3); 13C NMR (100 MHz, CDCl3): d=
158.2 (C), 136.3 (C), 131.3 (q, J=1.3 Hz, CH), 130.2 (CH),
125.6 (C), 125.4 (C), 125.7 (q, J=287.4 Hz, CF3), 123.6 (q,
J=3.0 Hz, CH), 122.2 (CH), 121.3 (CH), 121.3 (CH), 119.8
(CH), 113.9 (C), 112.5 (CH), 111.1 (CH), 79.5 (q, J=
30.1 Hz, C-CF3), 56.4 (CH3); 19F NMR (376 MHz, CDCl3):
d=À77.2 (s, 3F); IR (film): n=3321, 1584, 1459, 1412, 1286,
1235, 1173, 1160, 1113, 1036, 927, 743 cmÀ1; LR-MS (ESI):
m/z=320.1, mass calculated for [MÀH]À (C17H13F3NO2):
320.09; the enantiomeric excess was determined by HPLC
analysis using a Chiralpakꢂ IA column (hexane/i-PrOH: 88/
12, flow rate 1.0 mLminÀ1, l=225 nm): ent-major tr =
10.9 min and ent-minor tr =12.7 min.
(S)-2,2,2-Trifluoro-1-(1H-indol-3-yl)-1-(pyridin-3-yl)etha-
nol (4t): white solid; 71% yield; 68% ee; 1H NMR
[400 MHz, (CD3)2SO]: d=11.36 (s, 1H, NH), 8.64 (d, J=
1.8 Hz, 1H), 8.53 (dd, J=4.8, 1.6 Hz, 1H), 7.87 (d, J=
8.1 Hz, 1H), 7.50 (s, 1H), 7.45–7.36 (m, 2H), 7.31 (s, 1H,
OH), 7.09–7.04 (m, 1H), 7.01 (d, J=8.0 Hz, 1H), 6.86–6.81
(m, 1H); 13C NMR [100 MHz, (CD3)2SO]: d=149.2 (CH),
148.5 (CH), 136.5 (C), 135.2 (C), 135.1 (CH), 125.1 (C),
125.6 (q, J=287.5 Hz, CF3), 123.7 (q, J=2.5 Hz, CH), 123.0
(CH), 121.5 (CH), 120.3 (CH), 119.0 (CH), 112.0 (C), 111.8
(CH), 74.9 (q, J=29.1 Hz, C-CF3); 19F NMR [376 MHz,
(CD3)2SO]: d=À76.1 (s, 3F); IR (film): n=3277, 1424, 1264,
1247, 1166, 1041, 1028, 889, 734, 708 cmÀ1; LR-MS (ESI): m/
z=293.1, mass calculated for [M+H]+ (C15H12F3N2O):
293.09; the enantiomeric excess was determined by HPLC
analysis using a Chiralpakꢂ IC column (hexane/i-PrOH: 88/
12, flow rate 1.0 mLminÀ1, l=225 nm): ent-major tr =
8.8 min and ent-minor tr =11.2 min.
1,1,1-Trifluoro-2-(1H-indol-3-yl)-5-phenylpentan-2-ol (4u):
40% yield (conv. >80%); ee <2%; 1H NMR (400 MHz,
CDCl3): d=8.13 (bs, 1H, NH), 7.73 (d, J=8.1 Hz, 1H), 7.34
(dm, J=8.2 Hz, 1H), 7.25–7.03 (m, 8H), 2.72–2.50 (m, 2H),
2.42 (bs, 1H, OH), 2.36 (ddd, J=14.0, 12.5, 4.6 Hz, 1H),
2.08 (ddd, J=14.1, 12.1, 4.6 Hz, 1H), 1.80–1.67 (m, 1H),
1.62–1.47 (m, 1H); 13C NMR (100 MHz, CDCl3): d=141.6
(C), 136.5 (C), 128.4 (2CH), 128.3 (2CH), 126.1 (q, J=
285.8 Hz, CF3), 125.9 (CH), 125.1 (C), 123.6 (d, J=1.3 Hz,
CH), 122.3 (CH), 120.8 (q, J=1.6 Hz, CH), 120.3 (CH),
112.4 (C), 111.4 (CH), 76.7 (q, J=29.6 Hz, C-CF3), 35.6
(CH2), 34.1 (CH2), 24.4 (CH2); 19F NMR (376 MHz, CDCl3):
d=À80.9 (s, 3F); the enantiomeric excess was determined
by HPLC analysis using a Chiralpakꢂ IA column (hexane/i-
PrOH: 80/20, flow rate 1.0 mLminÀ1, l=225 nm): ent-1 tr =
5.9 min and ent-2 tr =7.7 min.
(R)-1-(2-Chlorophenyl)-2,2,2-trifluoro-1-(1H-indol-3-yl)-
ACHTUNGTRENNUNG
ethanol (4p): white solid; 68% yield; 86% ee; 1H NMR
(400 MHz, CDCl3): d=8.23 (s, 1H, NH), 7.92 (dm, J=
7.5 Hz, 1H), 7.38–7.30 (m, 4H), 7.27–7.25 (m, 1H), 7.17
(ddd, J=8.2, 7.0, 1.1 Hz, 1H), 7.12 (d, J=8.0 Hz, 1H), 6.96
(ddd, J=8.1, 7.0, 1.0 Hz, 1H), 3.75 (s, 1H, OH); 13C NMR
(100 MHz, CDCl3): d=136.1 (C), 134.8 (C), 133.6 (C), 131.9
(CH), 130.1 (q, J=2.3 Hz, CH), 130.0 (CH), 126.7 (CH),
125.3 (C), 125.2 (q, J=286.6 Hz, CF3), 124.1 (q, J=2.3 Hz,
CH), 122.5 (CH), 120.2 (2CH), 113.5 (C), 111.3 (CH), 77.6
(q, J=30.3 Hz, C-CF3); 19F NMR (376 MHz, CDCl3): d=
À75.5 (s, 3F); IR (film): n=3411, 3061, 1547, 1459, 1431,
1339, 1270, 1171, 1015, 929, 889, 741 cmÀ1; LR-MS (ESI): m/
z=324.0, mass calculated for [MÀH]À (C16H10ClF3NO): m/
z=324.04; the enantiomeric excess was determined by
HPLC analysis using a Chiralpakꢂ ID column (hexane/i-
PrOH: 90/10, flow rate 1.0 mLminÀ1, l=225 nm): ent-minor
tr =6.0 min and ent-major tr =7.1 min.
(S)-1-(3-Bromophenyl)-2,2,2-trifluoro-1-(1H-indol-3-yl)-
ACHTUNGTRENNUNG
ethanol (4q): white solid; 95% yield; 75% ee; 1H NMR
(400 MHz, CDCl3): d=8.26 (s, 1H, NH), 7.81 (s, 1H), 7.48–
7.42 (m, 3H), 7.37 (dm, J=8.2 Hz, 1H), 7.21–7.13 (m, 3H),
6.97 (ddd, J=8.1, 7.0, 1.0 Hz, 1H), 2.90 (s, 1H, OH);
13C NMR (100 MHz, CDCl3): d=139.9 (C), 136.2 (C), 131.7
(CH), 130.6 (q, J=1.1 Hz, CH), 129.5 (CH), 126.5 (q, J=
1.0 Hz, CH), 125.0 (q, J=286.4 Hz, CF3), 124.8 (C), 123.1
(q, J=3.1 Hz, CH), 122.9 (CH), 122.2 (C), 120.7 (CH), 120.5
(CH), 113.3 (C), 111.3 (CH), 76.6 (q, J=29.9 Hz, C-CF3);
19F NMR (376 MHz, CDCl3): d=À77.3 (s, 3F); IR (film):
n=3448, 3411, 3066, 1459, 1421, 1338, 1273, 1164, 1040, 944,
739 cmÀ1; LR-MS (ESI): m/z=367.9, mass calculated for
[MÀH]À (C16H10BrF3NO): 367.99; the enantiomeric excess
was determined by HPLC analysis using a Chiralpakꢂ IA
column (hexane/i-PrOH: 95/5, flow rate 2.0 mLminÀ1, l=
225 nm): ent-major tr =13.0 min and ent-minor tr =14.7 min.
1-(4-Chlorophenyl)-2,2,2-trifluoro-1-(1H-pyrrolo[2,3-b]-
pyridin-3-yl)ethanol (5b): white solid; 82% yield; 62% ee;
1H NMR [400 MHz, (CD3)2SO]: d=11.89 (s, 1H, NH), 8.19
(d, J=4.5 Hz, 1H), 7.56–7.49 (m, 3H), 7.43 (d, J=8.3 Hz,
2H), 7.38 (d, J=7.9 Hz, 1H), 7.29 (s, 1H, OH), 6.93 (dd, J=
7.9, 4.7 Hz, 1H); 13C NMR [100 MHz, (CD3)2SO]: d=148.6
(C), 143.2 (CH), 138.2 (C), 133.1 (C), 129.2 (CH), 128.6
(CH), 125.6 (q, J=287.5 Hz, CF3), 128.0 (2CH), 126.9, 124.0
Adv. Synth. Catal. 0000, 000, 0 – 0
6
ꢀ 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
ÞÞ
These are not the final page numbers!